Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet regimen for managing HIV infection. This drug unites three key antiviral drugs: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by blocking the HIV's ability to copy within the body, significantly reducing the viral burden. For many individual